Meet Our Speakers!

We have an amazing agenda of panelists. Here you can find their full bios.

Robert Galvin

Dr. Robert Galvin is the Chief Executive Officer of Equity Healthcare (EH), which oversees the management of health care for firms owned by private equity companies. The focus is on using purchasing power to create innovative ways to achieve higher value health care, through improved population health, clinical quality and delivery system reforms. Currently, EH encompasses over 30 companies with healthcare spending exceeding $1.5B annually.

Before joining Blackstone as a Senior Advisor, Dr. Galvin was Executive Director of Health Services and Chief Medical Officer for General Electric (GE) for fifteen years, where he was in charge of the design, financial and clinical performance of GE’s health programs. He was also responsible for health policy strategies affecting employees. Dr. Galvin is a nationally recognized leader in the areas of market-based health policy and financing, quality measurement and payment reform.

His work has been widely published in the New England Journal of Medicine and Health Affairs and he was a co-founder of the Leapfrog Group and founder of two other groups, Bridges to Excellence and Catalyzing Payment Reform, all innovative non-profits that have helped drive the quality agenda. Dr. Galvin is a member of the Institute of Medicine and sits on the IOM’s Board on Health Care Services. He is also on the Board of Directors of the National Quality Forum and a member of the National Advisory Council for the Agency for Healthcare Research and Quality (AHRQ). Dr. Galvin is Professor Adjunct of Medicine and Health Policy at Yale. His work has received awards from the National Business Group on Health, the Healthcare Financial Management Association and the National Coalition for Cancer Survivorship. He is a fellow of the American College of Physicians.

Megan Ranney

MD, MPH, FACEP

Dr. Megan L. Ranney is an emergency physician, researcher, and leading advocate for innovative approaches to public health. She is the Dean of the Yale School of Public Health, the C.-E. A. Winslow Professor of Public Health, and a Professor of Emergency Medicine at Yale University. Under her leadership, the school is pursuing a bold new strategic vision of linking science and society, making public health foundational to communities everywhere. Her first-hand experiences as a member of the Peace Corps and a practicing physician have fueled her commitment to high-quality science.

She is a national leader in restarting the science of firearm injury prevention as a health issue. Her work on violence prevention, the use of technology to augment prevention, and the role of systems-level change in care has been published over 200 times. She is an elected member of the National Academy of Medicine and the Connecticut Academy of Science and Engineering, a Fellow of the American College of Emergency Physicians, and a member of the Aspen Global Leadership Network.

In addition to her scholarly work, she has harnessed social media to spark large public health movements, such as securing and distributing over 17 million units of donated PPE at the peak of the COVID-19 pandemic. She started two successful non-profits and serves as a board member on national and international organizations that work to use science to reduce firearm injury, improve science communication, and enhance emergency care, among other leadership roles. She has provided Congressional testimonies and other expertise to the U.S. Surgeon General and the White House across multiple presidential administrations. She is a sought-after media presence, with over 1,000 national and international appearances that translate public health messages and science for the public.

Before her Deanship at Yale, Dr. Ranney was previously the Warren Alpert Endowed Professor of Emergency Medicine, Deputy Dean of the School of Public Health, and Founding Director of the Brown-Lifespan Center for Digital Health at Brown University. Dr. Ranney earned her bachelor's degree in history of science, graduating summa cum laude from Harvard University; her medical doctorate, graduating Alpha Omega Alpha from Columbia University; and her master’s degree in public health from Brown University. She completed her residency in Emergency Medicine and a fellowship in Injury Prevention Research at Brown University.

Rachael Bedard

Dr. Rachael Bedard is an internist, geriatrician and palliative care physician. She is also a contributing Opinion writer at The New York Times, and a Type Media fellow.

She doctors, teaches, writes and advocates at the intersections between health, ideas, politics and human rights. Her clinical work is primarily with homeless and justice-involved elders, especially people who are recurrently incarcerated in the final decades of their lives. From 2016-2022 she was a physician on Rikers Island. She currently sees patients at a safety net clinic in Brooklyn.

From 2023-2024, She sat on the New York City Board of Correction. From 2022-2024 she founded and ran an organization that supported the pro-choice side of state ballot initiatives.

Dr. Bedard studied History at Brown University and completed medical training at the Mount Sinai Hospital in New York and the Cambridge Health Alliance in Cambridge, Massachusetts.

Reed Tuckson

MD, FACP

Reed V. Tuckson, M.D., FACP, is Managing Director of Tuckson Health Connections, LLC, a vehicle to advance initiatives that support optimal health and wellbeing through the intersection of health promotion and disease prevention; applied data and analytics; enhanced quality and efficiency in care delivery; and the application of telehealth and biotech innovations.

Currently, Dr. Tuckson’s focus is on advancing his work as a co-founder of the Black Coalition Against COVID, a multi-stakeholder and interdisciplinary effort working to mitigate the COVID-19 pandemic in Washington, D.C. and nationally.

Previously, he enjoyed a long tenure as Executive Vice President and Chief of Medical Affairs for UnitedHealth Group, a Fortune 20 health and wellbeing company and has served as Senior Vice President for Professional Standards of the AMA; Senior Vice President of the March of Dimes Birth Defects Foundation; President of the Charles R. Drew University of Medicine and Science; and Commissioner of Public Health for the District of Columbia.

Dr. Tuckson serves on the boards of Adverum Biotechnologies; CTI BioPharma; the Henry Schein Company and numerous not-for profit health boards, including Freedom House which is dedicated to advancing democracy throughout the world. A recognized leader in his field, Dr. Tuckson is honored to have been appointed to leadership roles at the National Institutes of Health; National Academy of Medicine; and numerous Federal Advisory Committees. He has been recognized several times by Modern Healthcare Magazine’s listing of the “50 Most Powerful Physician Executives” in health care. He is a graduate of Howard University, Georgetown University School of Medicine, and the Hospital of the University of Pennsylvania’s General Internal Medicine Residency and Fellowship Programs, where he was also a Robert Wood Johnson Foundation Clinical Scholar studying at the Wharton School of Business.

Farzad Mostashari

MD, ScM

Farzad Mostashari, MD, is the co-founder and CEO of Aledade, a physician‑led, national leader in value‑based care whose mission is to deliver better health, better care and lower costs, creating a health care system that is good for patients, good for practices and good for society.

Mostashari’s long-term vision for Aledade, a public benefit corporation, is rooted in the belief that primary care doctors are best positioned to lead health care reform across the United States and earn shared savings for proactively managing the quality and total cost of patient care. This vision was outlined in a JAMA article co-authored by Mostashari in 2014, the year he co-founded Aledade. Under Mostashari’s leadership, Aledade helps more than 3,000 primary care organizations in 46 states and the District of Columbia improve patient outcomes and achieve financial success by keeping people healthy.

Before joining the federal government, Mostashari served as assistant commissioner at the New York City Department of Health and Mental Hygiene. There, he designed and led the Primary Care Information Project, which equipped 1,500 physicians in under-resourced communities with EHRs and focused on using data for public health action. He also served as an epidemic intelligence service officer at the Centers for Disease Control and Prevention (CDC), where he was a lead investigator in the West Nile virus outbreak and anthrax attacks.

Mostashari currently serves as the chair of the board of directors for Resolve to Save Lives, a global health organization focused on accelerating action against the world's deadliest health threats. Mostashari frequently speaks on health policy and technology adoption to improve public health. He recently co-authored an article in NEJM Catalyst on how to significantly expand value-based care within Medicare. He earned a Bachelor of Arts in Biochemistry from Harvard University, a Master of Science in Population Sciences from the Harvard School of Public Health, and a Doctor of Medicine from the Yale School of Medicine.

Sejal Hathi

MD, MBA

Dr. Hathi is a board-certified internal medicine physician and nationally recognized public health leader who serves as the Director of the Oregon Health Authority, where she oversees health care delivery, public health, and Medicaid services for the State of Oregon. Previously, she served as New Jersey’s Deputy Health Commissioner and State Health Officer and the Biden-Harris White House’s Senior Policy Advisor for Public Health, shaping domestic policy priorities across behavioral health, climate health, and medical supply chain policy. Dr. Hathi trained in internal medicine at Massachusetts General Hospital and has held faculty appointments at both Johns Hopkins and Harvard; she is currently a part-time clinical assistant professor and hospitalist at Stanford School of Medicine. Dr. Hathi earned her BS with honors from Yale and her M.D. and M.B.A. from Stanford, where she was a Harry S. Truman Scholar and Paul & Daisy Soros Fellow.

Reshma Ramachandran

MD, MPP, MHS

Reshma Ramachandran, MD, MPP, MHS is a family medicine physician, health services researcher, and Assistant Professor within the Section of General Internal Medicine in the Department of Medicine at Yale University. She has published several peer-reviewed research articles and commentaries on the realignment of incentives for healthcare stakeholders including pharmaceutical companies, hospitals, and universities towards prioritizing equitable patient access to safe, effective health technologies. She co-directs the Yale Collaboration for Regulatory Rigor, Integrity, and Transparency (CRRIT), an interdisciplinary initiative aligning research on medical product evaluation, approval, and coverage with the goal of advancing policies that improve patient health and healthcare. Her research has led her to be invited to brief policymakers and testify before the U.S. Congress, including before the U.S. House of Representatives Committee on Energy and Commerce and Ways and Means Committee as well as the U.S. Senate Health, Education, Labor, and Pensions Committee.

Previously, Dr. Ramachandran was research faculty as part of the Innovation + Design Enabling Access (IDEA) Initiative at the Johns Hopkins Bloomberg School of Public Health. Dr. Ramachandran trained in both medicine at the Alpert Medical School at Brown University and in public policy at the Harvard Kennedy School of Government. She completed her family medicine residency at Kaiser Permanente Los Angeles Medical Center and fellowship training at the National Clinician Scholars Program at Yale University. She is a Reimagining America fellow with the Roosevelt Institute.

Jason Schwartz

PhD

Jason L. Schwartz is an Associate Professor in the Department of Health Policy and Management at the Yale School of Public Health. His research examines vaccines and vaccination policy, decision-making in medical regulation and public health policy, and the structure and function of scientific expert advice to government. The overall focus of his work is on the ways in which evidence is interpreted, evaluated, and translated into regulation and policy in medicine and public health. His publications have appeared in The New England Journal of Medicine, JAMA, BMJ, The Lancet, Health Affairs, and other leading journals in medicine, health policy, and public health. His research, analysis, and perspectives have been featured in the New York Times, Washington Post, CNN, NPR, BBC, and elsewhere. During the COVID-19 pandemic, he was a member of Connecticut Gov. Ned Lamont's COVID-19 Vaccine Advisory Group and co-chair of its Science Subcommittee, and he currently serves on an advisory committee to the Connecticut Commissioner of Public Health and the Board of Advisors for the Vaccine Integrity Project. He is a graduate of Princeton University (AB) and the University of Pennsylvania (MBE, PhD).

Xiaoyan Huang

MD, MHCM, FACC, FACP

Xiaoyan Huang, YC '91, MD, MHCM, FACC is a cardiologist and Chief Medical Officer of the High Performing Network of Oregon. Dr. Huang graduated from Yale College, Stanford Medical School, and Harvard T. H. Chan School of Public Health. Having served as Chief of Clinical Cardiology at Providence Heart Institute and Medical Staff President, Dr. Huang’s work has focused on high value specialty care in the medical neighborhood. She has published on these topics in the New England Journal of Medicine, Circulation, Harvard Business Review, New England Journal of Medicine Catalyst, etc. Dr. Huang has also published on the broader topics of her personal journey as an immigrant in The Washington Post.

In gratitude to Yale, Dr. Huang spends much of her spare time volunteering for Yale. She is a past president of the award-winning Yale Club of Oregon and SW Washington. She has served on the board of the Yale Alumni Service Corp, YaleWomen Governing Council, Yale Alumni Magazine Advisory Board, and University Council. She is one of the founding administrators of the Yale Alumni Facebook Group, which now has over 22,900 alumni members. Since 2016, Dr. Huang has served on the Yale Alumni Association Board of Governors as a board member, chair of Volunteer Engagement, Alumni Fellow, Yale Medal, Volunteer Development Committees, as Executive Officer, Vice Chair, Chair, and currently the Immediate Past Chair. In 2026, Dr. Huang is serving as the global chair of Yale Day of Service.

Bhramar Mukherjee

PhD, MS

Professor Bhramar Mukherjee is the Anna M.R. Lauder Professor of Biostatistics and Professor of Chronic Disease Epidemiology at the Yale School of Public Health (YSPH). Professor Mukherjee serves as the inaugural Senior Associate Dean of Public Health Data Science and Data Equity at YSPH. She holds a secondary appointment in the Department of Statistics and Data Science and is affiliated with the MacMillan Center and the Institute for the Foundations of Data Science. She serves on the Yale Cancer Center Director’s cabinet.

Prior to joining Yale University in 2024, Dr. Mukherjee built a distinguished career at the University of Michigan from 2006-2024, where she was appointed as John D. Kalbfleisch Distinguished University Professor of Biostatistics (2023-2024), Siobán D. Harlow Collegiate Professor of Public Health (2023-2024), John D. Kalbfleisch Collegiate Professor of Biostatistics (2015-2023) and Chair of the Department of Biostatistics (2018-2024). She had several other significant leadership appointments at Michigan including an institutional appointment as the inaugural Assistant Vice President for Research for Research Data Services Strategy (2023-2024); Associate Director for Quantitative Data Sciences (2019-2024), Associate Director for Cancer Control and Population Sciences (2015-2018) at the University of Michigan Rogel Cancer Center. She also held professorial appointments in Epidemiology and Global Public Health. Professor Mukherjee was actively engaged with the U-M Precision Health initiative, as well as the Michigan Institute of Data Science (MIDAS). She served as the founding director of a flagship undergraduate summer program in big data from 2015-2024. She has supervised twenty doctoral students and three post-doctoral fellows

Jan-Felix Schneider

MSc

Jan-Felix is the co-founder of Arlo - a health insurance technology company. Before starting Arlo, he spent 3.5 years at Palantir in New York City as a Deployment Strategist working with clients in health care, aviation, and the telecom industry.

Prathibha Varkey

MBBS, MBA

Prathibha Varkey, MBBS, MPH, MHPE, MBA, MA (privatum), is president of Mayo Clinic Health System (MCHS). As president, Dr. Varkey leads 14,000 employees serving 16 community hospitals and 40 multispecialty clinics across 30 communities in Minnesota, Wisconsin and Iowa. Dr. Varkey is also a Professor of Medicine and Preventive Medicine at Mayo Clinic College of Medicine and Science.

Prior to her current role, Dr. Varkey served as the Chief Executive Officer and President of the Yale New Haven Health Northeast Medical Group, and as the President and Chief Executive Officer of the Seton Clinical Enterprise. From 2001 to 2013, Dr. Varkey held leadership positions at Mayo Clinic in Rochester, including Associate Chair of the Department of Medicine; medical director of Ask Mayo Clinic; program director of the Preventive Medicine Fellowship, and Director of the Quality Improvement Curriculum.

A nationally recognized expert in Quality Improvement, Dr.Varkey is a past president of the American College of Medical Quality, has authored over 80 publications and is the editor of two books: Medical Quality Management and Mayo Clinic Board Review on Preventive Medicine and Public Health. She was recognized by Modern Healthcare as one of the “Top 25 Women Leaders in Healthcare” for 2023. Dr.Varkey earned her MBBS from the Christian Medical College in Vellore, India; a Masters of Public Health from the Harvard School of Public Health; a Masters of Health Professions Education from the University of Illinois, Chicago; and a Masters of Business Administration from the Carlson School of Management at the University of Minnesota. She completed her internal medicine residency at the Yale New Haven Health Hospital of Saint Raphael and a preventive medicine fellowship at Mayo Clinic in Rochester. She has an honorary Master of Arts degree from Yale University.

Dr. Varkey and her husband, Pravin, have a young daughter and live in
Rochester, Minnesota.

Luca Maini

PhD

Luca Maini, PhD, is an Assistant Professor of Health Care Policy at Harvard Medical School and a Research Fellow at the Cecil G. Sheps Center for Health Services Research. Before coming to the Department of Health Care Policy he was an Assistant Professor of Economics at the University of North Carolina at Chapel Hill.

Maini’s research focuses on competition and regulation in healthcare markets. His particular focus is on the pharmaceutical market, where he has studied the impact of price regulation that references prices across markets, the reaction of originator biologics to biosimilar entry, and the effect of M&A activity on the pricing and coverage of branded drugs. Maini received a BA in Economics and a BS in Mathematics from the University of Chicago, and his PhD in Economics from Harvard University.

Michael Hund

MBA

Michael Hund, MBA, is an award winning CEO with more than 20 years of experience in the innovative business models of venture philanthropy, impact investing and medtech entrepreneurship. His leadership has been highlighted by MIT, Yale, Harvard, Stanford, Cambridge, Forbes, and the Milken Institute.

He is the CEO of EB Research Partnership, a game changing medical research organization dedicated to curing EB and scaling their model to rare disease. Under his leadership EBRP has raised more than $80 million to transform the landscape from 2 to over 50 clinical trials and accelerated 3 FDA approved treatments in the last two years. He is Executive Producer of the award-winning Netflix documentary Matter of Time and Executive Producer of Venture into Cures, a movement combining stories of the patient and medical communities with musicians and actors. Previously he served as the Director for the Multiple Myeloma Research Foundation and Paul Newman’s Hole in the Wall Gang, working on behalf of children battling life threatening illnesses.

Michael received his MBA from Yale University, CORe credential from Harvard Business School, and a degree in Philosophy from the University of Kansas. He is the recipient of the MIT Solve Innovation Award, iHeart Media’s CEOs You Should Know, the Milken Institute’s Changemaker and LeadersLink, Social Innovations Journal Leadership Award, Top 100 Magazine Innovators, and IAOTP’s Top CEO of the Year in Medical Research.

Kasia Lipska

MD, MHS

Kasia Lipska is a physician and health services researcher whose work targets one of the quietest failures in American medicine: the routine denial of lifesaving care through price, complexity, and neglect. Trained as a clinician, she has spent years caring for people with diabetes who are doing everything asked of them, yet are forced to make dangerous tradeoffs because essential treatments are priced beyond reach. Insulin is a central example in her work, illustrating how a century-old medicine can still be used to quietly rob people of years of life through cost alone.

Lipska’s research documents how insurance design, cost sharing, and policy choices translate directly into rationing, preventable complications, and avoidable deaths, particularly among people with fewer financial and social resources. She is currently Associate Professor of Endocrinology at the Yale School of Medicine.

Anup Sabharwal

MD, MBA, FACC, FACE, FESC, FAHA, FASPC, FNLA

Anup Sabbarwal recently joined Syneos Health as Vice President, Head of Research and Development and Scientific Strategy in Cardiovascular, Renal, and Metabolic Medicine.

Prior to joining Syneos Health, Anup served as the Senior Medical Director and Head of US Mergers and Acquisition Scientific Advisory at Novo Nordisk. He joined Novo Nordisk in 2011 as an Endocrine Scientific Director, served as the Director of Clinical Strategy, then transitioned to the lead and National Director of the Regional Medical Scientist team, which spearheaded new therapeutic areas for the enterprise, including Cardiology and Nephrology. He moved to the Pipeline Team and led early asset incubation, and led the Neuro Health Team, then became the US medical lead for Cell Therapy Programs. During his tenure there he continued his growth and development, he completed his MBA in Healthcare at Florida International University Chapman Graduate School of Business, the Artificial Intelligence in Healthcare Program at Massachusetts Institute of Technology (MIT), the Genomics and Genetics Program at Stanford University, and the Mergers and Acquisitions: Strategy, Execution, and Post-Merger Management Program at Harvard Business School.

He is also a voluntary Clinical Professor in Endocrinology, Diabetes, and Metabolism at Florida International University Herbert Wertheim College of Medicine and the Chapman Graduate School of Business.

Nicola Hawley

PhD

Dr. Nicola Hawley is an Associate Professor of Epidemiology (Chronic Disease) at the Yale School of Public Health and holds a secondary appointment in the Department of Anthropology at Yale University. She also serves as Associate Director for Dissemination and Implementation Science at the Yale Center for Clinical Investigation. Trained as a human biologist, Dr. Hawley is an internationally recognized expert in maternal and child health, with particular expertise in the developmental origins of obesity and related chronic diseases.

Her interdisciplinary research bridges epidemiology, anthropology, and global health to examine how early life exposures—during pregnancy, infancy, and childhood—shape long-term health. She employs a life-course perspective and mixed-methods approaches across cross-sectional, cohort, and randomized controlled trial designs to identify critical windows for intervention. A hallmark of her work is the integration of community-engaged and culturally responsive strategies to address maternal and child health disparities in under-resourced and Indigenous settings.

While her primary research focus is on Pacific Islander communities in Samoa, American Samoa, and the US, Dr. Hawley has built long-standing collaborations in South Africa, Uganda, New Zealand, and the United States, contributing to global evidence on perinatal health, childhood growth, and intergenerational disease risk. Her current research portfolio includes NIH- and PCORI-funded studies addressing gestational and Type 2 diabetes, prevention of excess gestational weight gain, childhood obesity, and cardiometabolic risk across generations. She is also leading efforts to develop culturally grounded interventions that span pregnancy through adolescence, aiming to disrupt the intergenerational transmission of chronic disease. As a mentor, Dr. Hawley plays a central role in training the next generation of US and global health scientists, serving as primary mentor on multiple NIH career development awards (K01, K99, F30, F31) focused on Pacific Islander health.

Wendy Barr

MD, MPH, MSCE, FAAFP

Wendy B. Barr MD, MPH, MSCE, FAAFP is the Founding Residency Program Director for the Yale Family Medicine Residency Program at Lawrence + Memorial Hospital. She is dedicated to growing and strengthening the primary care workforce to equitably improve the health of communities. This guides her work in supporting and expanding family medicine training programs and research to inform how to best train the next generation of comprehensive personal physicians who provide excellent care to all patients.

Dr. Barr is a graduate of Tufts University School of Medicine MD/MPH program and completed her family medicine residency at the Lawrence Family Medicine Residency in Lawrence, MA. She then went on to complete a research and faculty development fellowship at the University of Pennsylvania School of Medicine where she also received a Masters of Science in Clinical Epidemiology. Dr. Barr is a Distinguished Scholar for the American Board of Family Medicine where she is conducting research on GME outcomes and GME program improvement and is the co-co-Principal Investigator for the Family Medicine Residency Outcome Project, and the ABFM Annual National Resident Survey.

Prior to coming to Yale, Dr. Barr was the Residency Program Director, ACGME Designated Institutional Officer (DIO), and Vice President of Clinical Education at the Greater Lawrence Family Health Center in Lawrence, MA where she helped to lead the family medicine residency program’s transition from a three year to four year curriculum as part of the national ACGME Length of Training Pilot and multiple other residency redesign and innovation initiatives. She has served on the Board of Directors of the Association of Family Medicine Residency Directors (AFMRD) from 2019-2023 including serving as President from 2021-2022 and she served on the Board of Directors for NAPCRG, an international primary care research professional association. She currently serves on multiple national family medicine education and research committees and taskforces. Her research interests include the care of pregnant people and children by family physicians, and developing evidence to support family medicine residency redesign and competency based medical education and board eligibility.

Bridget Basile

PhD, MA, RN, FNP-BC

Dr. Bridget Basile is a nurse-scientist with over a decade of clinical experience working as a family nurse practitioner providing primary care to underserved communities in urban and rural areas and a registered nurse in inpatient pediatric oncology and stem cell transplant. She also has experience caring for women and their families as a doula and certified breastfeeding specialist. Prior to entering nursing, she worked as an anthropologist on international development projects funded by agencies such as the World Bank and USAID. Dr. Basile holds a PhD from Yale University, an MSN from the University of California Los Angeles, a BSN from The Johns Hopkins University, and a BA and MA in Anthropology from Boston University. She completed an NIH-funded Rural Health Equity Postdoctoral Fellowship at the University of Minnesota School of Public Health.

Dr. Basile’s research aims to improve birth outcomes for women and birthing people marginalized by intersections of race, socioeconomic status, and geography by improving the experience and quality of perinatal care and interactions with the health system. Dr. Basile’s program of research has been supported by the Association for Women’s Health, Obstetric, and Neonatal Nurses, the March of Dimes, the Heilbrunn Family Center for Research Nursing at the Rockefeller University, the Institute for Advanced Study at the University of Minnesota, and the Health Equity Research Working Group at University of Minnesota School of Public Health.

Valerie Thomas

MEd

Valerie is Head of Patient Advocacy and Alliances at Comanche Biopharma, where she leads collaborations with advocacy groups, professional societies, and key stakeholders to ensure the patient voice shapes clinical development and business strategy in preeclampsia. She is known for cultivating strong cross-functional relationships and translating patient insights into meaningful action across the organization.

A preeclampsia survivor herself, Valerie brings both deep personal conviction and 25 years of biopharmaceutical experience spanning patient advocacy, medical affairs, alliance management, commercial operations, and product launch excellence. Prior to Comanche, she held leadership roles at Novartis, The Medicines Company, and Pfizer, where she contributed to medical education, strategic commercial initiatives, and stakeholder engagement.

Valerie is deeply committed to improving outcomes for individuals and families affected by preeclampsia, a mission she pursues both professionally and personally. She holds a B.A. in Psychology from The College of Wooster and an M.Ed. in Higher Education Administration from Bowling Green State University.

Ingrid Katz

MD, MHS

Dr. Ingrid T. Katz is a nationally recognized physician-scientist and Director of the Yale Institute for Global Health. In this role, she leads the expansion of global health research, clinical, and educational initiatives across Yale. She holds a joint appointment in the Yale School of Medicine and Yale School of Public Health. Dr. Katz also serves as Chief of Evidence and Program Innovation in the Bureau of Global Health Security and Diplomacy at the U.S. Department of State.

Trained in infectious diseases, Dr. Katz’s global health expertise spans Southern Africa and Southeast Asia, where she has led federally funded initiatives focused on improving HIV care and advancing sustainable, equity-centered health interventions. For nearly 20 years, she has maintained NIH funding and long-term research partnerships with the University of Cape Town and the University of the Witwatersrand in South Africa. Her work has been recognized by UNAIDS and through her participation as an inaugural member of the Global Council on Inequality, AIDS, and Pandemics.

Prior to joining Yale, Dr. Katz spent 16 years on the faculty of Harvard Medical School and served as Associate Faculty Director at the Harvard Global Health Institute, where she co-led efforts addressing major global health threats, including the COVID-19 pandemic and the health impacts of climate change. She has also been deeply committed to mentorship and leadership development, helping to create and fund the LEAD Fellowship supporting women global health leaders from low- and middle-income countries. Her contributions have been recognized with the A. Clifford Barger Excellence in Mentoring Award and the Dean’s Award for an Emerging Leader in Women’s Careers. Dr. Katz earned her bachelor’s degree from Amherst College, a Master of Health Science from the Johns Hopkins Bloomberg School of Public Health, and her medical degree from the University of California, San Francisco.

Jennifer E. Miller

PhD

Jennifer E. Miller, PhD, is Co-Director of the Program for Biomedical Ethics and an Associate Professor in Yale School of Medicine. She is also the Director of the Good Pharma Scorecard (an index that ranks and rates pharmaceutical companies on their bioethical performance) and Founder of the nonprofit Bioethics International.

Her current research focuses on ethics, equity and governance in drug, vaccine, and medical device research, development, and accessibility as well as in the ethics of healthcare data sharing. She also specializes in developing and using metrics to enhance accountability and social responsibility in biomedical innovation.

Prior to joining Yale’s faculty, she was an Assistant Professor (tenure track) in NYU School of Medicine and completed training in physics, regulatory governance, bioethics, and ethics at Fordham University, Duke University, Regina Apostolorum Pontifical University, and Harvard University.

Sharon Chekijian

MD, MPH

Dr. Chekijian joined the Yale School of Medicine faculty in 2007 as an Associate Professor in the Department of Emergency Medicine. She is faculty member in the Section of Global Health and International Emergency Medicine as well as in the Section of Administration. She has served as inaugural Medical Director of patient experience since 2011. She served as the Medical Director of the Physician Assistant and Nurse Practitioner group in the Department of Emergency Medicine from 2007-2024. Dr. Chekijian is a seasoned educator and is the founding Medical Director of the APP post-graduate training program. She completed the Yale Medical Education Fellowship in 2014. At Yale School of Medicine she serves on the Executive Admissions Committee, the Educational Policy and Curriculum Committee and the Executive Committee of the Status of Women in Medicine.

Her research interests lie in global emergency medicine and include emergency care systems' development in low and middle-income countries, unintentional injury prevention in low and middle-income countries, as well as stroke and cardiac care in low and middle-income countries. Dr. Chekijian has led and participated in projects in the Republic of Armenia, Uganda, and Iraq. She has consulted for the World Bank and the US Department of State. She is an active member of the Stroke Initiative Advisory Task-Force for Armenia (SIATA).

In 2020, Dr. Chekijian was awarded a Fulbright for her work to improve emergency care in Armenia by the establishment of a new emergency medicine residency program in cooperation with the National Institutes of Health of Armenia and supported from a research standpoint by the School of Public Health at the American University of Armenia. In July of 2025 she was appointed founding Chair of the Department of Emergency Medicine and Disaster Medicine at the National Institute of Health of the Republic of Armenia.

She is the host of Yale Global Health Insights Podcast that seeks to understand the personal drive behind the people that are at the forefront of Global Health at Yale. Dr. Chekijian co-produced a film that addresses human rights as it relates to the Armenian Genocide of 1915 under the working title “The Hidden Map” that premiered at the Toronto Pomegranate Film Festival in 2019.

Lynka Ineza

MSPH

Lynka Ineza, MSPH is a Program Manager at the Yale Global Health Leadership Initiative (GHLI), where she leads multi‑country leadership development programs that strengthen health systems across francophone and anglophone contexts. Her work focuses on equipping health leaders and teams with the skills and tools needed to address complex system challenges, improve performance, and drive sustainable change.

She collaborates closely with Ministries of Health, academic institutions, and global partners such as Gavi, the Vaccine Alliance, to design and implement programs that integrate leadership development, data‑driven decision‑making, and systems thinking. At GHLI, Lynka has led flagship initiatives including the Expanded Programme on Immunisation Leadership and Management Program (EPILAMP) across 26 countries; the Strategic Training Executive Program (STEP) 2.0 for vaccine supply chain managers in Zambia and Cameroon; Research Leadership and Mentorship Programs in Chad; and Leading ICUs for Transformation (LIFT), which prepares ICU leadership teams in Australia and Aotearoa New Zealand to drive improvements in performance.

Her work has also included the successful adaptation of leadership development programming to virtual formats during COVID‑19. Prior to joining Yale, Lynka served as a Technical Advisor with The Carter Center’s Guinea Worm Eradication Program in Chad and worked as a Consultant with World Vision in Mauritania and Sierra Leone, supporting global health program implementation and evaluation across diverse settings.

Peter Bach

Health policy and payment expert, pulmonary physician, and lung cancer epidemiologist, Peter has devoted his career to repairing defects in the healthcare delivery system that impede access to high-quality cancer care and working to ameliorate healthcare’s cost crisis. His work spans seminal studies including the identification of racial gaps in lung cancer care, the development of the first lung cancer risk prediction model (the “Bach model”), lead authorship on multiple lung screening guidelines, and definitional work on pharmaceutical pricing and value. Peter previously served as Senior Adviser at the US Centers for Medicare & Medicaid Services and mentor on many National Institutes of Health K awards. He has been elected to the National Academy of Medicine, American Society for Clinical Investigation, and the Johns Hopkins Society of Scholars.

Cary Gross

Dr. Cary Gross is a Professor of Medicine and Public Health and Director of the National Clinician Scholars Program at Yale. Dr. Gross completed his residency in Internal Medicine at New York Hospital-Cornell Medical Center and served as chief medical resident at Memorial Sloan-Kettering Cancer Center the following year. His research addresses comparative effectiveness, quality, and health equity, with a focus on cancer prevention and treatment. He aims to use real-world research to generate knowledge that will inform change in clinical care and health policy. He is a founding Director of Yale’s Cancer Outcomes Public Policy and Effectiveness Research Center (COPPER). His research has been supported by the National Cancer Institute, the American Cancer Society, among others. As a former Robert Wood Johnson Foundation Clinical Scholar, Dr. Gross has advanced training in biostatistics, epidemiology, research ethics, and outcomes research.

Chul S. Hyun

MD, PhD, MPH

Dr. Chul S. Hyun is a gastroenterologist and physician-scientist at Yale School of Medicine and the inaugural Director of the Gastric Cancer Prevention and Screening Program. His work focuses on prevention, early detection, and reducing disparities in gastric cancer through community-based approaches and migration-informed risk assessment, with an emphasis on policy-relevant solutions. He leads the Gastric Cancer Prevention Lab at Yale, advancing research at the intersection of clinical care, public health, and health equity.

Dr. Hyun received his B.S. from Johns Hopkins University and his M.D. from the University of Miami School of Medicine. He completed his Internal Medicine training at Georgetown University Medical Center and a Gastroenterology and Liver Fellowship at Yale University School of Medicine. He holds a Ph.D. in Biophysics from the University of Rochester School of Medicine and an MPH from Columbia University, and completed postdoctoral training in Physiology at the University of Chicago School of Medicine.

Dawn Mattoon

PhD

Dr. Dawn Mattoon is the Chief Executive Officer at Mercy BioAnalytics. She brings nearly 20 years of experience in the biotechnology industry and has held leadership positions in R&D, Strategy, and General Management for a series of exceptional companies including Invitrogen, Life Technologies, Thermo Fisher, and Cell Signaling Technology.

Prior to joining Mercy, Dr. Mattoon served as the Senior Vice President for Clinical Diagnostics at Quanterix, where she led the development and commercialization of the company’s first two FDA authorized diagnostic tests for COVID-19, and received Breakthrough Device designations from the FDA for diagnostic tests in Alzheimer’s Disease and Multiple Sclerosis. She has developed and commercialized products across a range of proteomic and genomic technologies and is thrilled by the opportunity to bring the highly innovative Mercy Halo diagnostic test portfolio to patients. Dr. Mattoon earned her Ph.D. in Genetics with a focus in signal transduction from Yale University, where she also completed her postdoctoral fellowship.

Tanmay Adya

Tanmay is the Head of Health Plan Product at Arlo, where he leads the development of their next-generation, AI-native health plan designed to deliver superior clinical outcomes and greater affordability. His work is centered on building personalized, consumer-centered services and healthcare experiences to overcome the challenges and hurdles seen with traditional health insurance.

With a career spanning the healthcare ecosystem, Tanmay brings experience in product management, corporate strategy, M&A, population health management, and entrepreneurship. Prior to joining Arlo, he held roles at innovative and established organizations such as Oak Street Health, HCSC, and ZS, working across sectors including value-based primary care, behavioral health, payer and "payvider," digital health, and pharma/MedTech. He studied Electrical Engineering and Technology & Management at the University of Illinois at Urbana-Champaign and is currently based in Chicago, IL.

Aline Maybank

MPH

Aline Maybank (YSPH '25) is an environmental health researcher at the George Washington University's Milken Institute School of Public Health who uses geospatial and statistical techniques to investigate how environmental conditions, including wildfire smoke and extreme heat, affect community health. She earned her Master of Public Health in Environmental Health Sciences and Climate Change from the Yale School of Public Health, where her thesis examined the chemical composition and source attribution of wildfire smoke. Aline is also a digital science communicator and recipient of science communication fellowships from the Museum of Science and the American Geophysical Union, and has previously worked for the NASA DEVELOP program, the Yale Center for Geospatial Solutions, and the United Nations Environment Programme (UNEP).

Colleen Fitzpatrick

Colleen M. Fitzpatrick, MD, MPA is a Pediatric Surgeon and an Associate Professor of Pediatrics and Surgery at Northwell Health's Cohen Children's Medical Center in New Hyde Park, NY and the Zucker School of Medicine at Northwell/ Hofstra University. She serves as the Surgical Quality Office at Cohen Children’s Medical Center.

Dr. Fitzpatrick completed her undergraduate and medical education at the University of Miami. She completed her general surgery training with the US Air Force in San Antonio, TX and was a pediatric surgery fellow at the Children's Hospital of Michigan in Detroit. She achieved the rank of Lt Colonel before completing her military commitment in 2016.

With a keen interest in climate change, planetary health, and healthcare sustainability, she completed her MPA in Environmental Policy and Sustainability Management from Columbia University in 2023. Dr. Fitzpatrick co-leads the Sustainability Committee at Cohen Children's Medical Center and serves on the Northwell Health System Sustainability Team. She is a published sustainability researcher and is working with the curriculum committee at the Zucker School of Medicine and the Graduate Medical Education Committee at Northwell Health to incorporate climate change and sustainability into the undergraduate and graduate medical education curricula. Dr. Fitzpatrick is also an alumna of the Cambridge Health Alliance Climate Organizing Fellowship.

Shalini Shah

Shalini Shah is a practicing board-certified pediatrician, environmental medicine physician, and assistant director for the Boston Children’s Pediatric Environmental Health Center (PEHC) and Region I Pediatric Environmental Health Specialty Unit (PEHSU). She attended medical school at the University of New England College of Osteopathic Medicine, completed her residency in pediatrics at the University of Massachusetts Medical School and her fellowship in pediatric and reproductive environmental health at Boston Children's Hospital.

Dr. Shah cares for patients in primary care pediatrics and environmental health clinic. Her work focuses on the intersection of the climate crisis, environmental justice, and children’s health and has been presented regionally and nationally. Her research centers on developing and implementing environmental screening (e.g. the Healthy Homes screener) and clinical education tools (e.g. ClimateRx) in clinical settings to strengthen families’ capacity to adapt to climate-related health risks. Dr. Shah also co-leads educational programs at the Region I PEHSU, Boston Children’s Hospital, and Harvard Medical School to integrate environmental and climate-related education across all stages of medical training — from high school and undergraduate students to medical trainees and practicing clinicians.

Muoi A. Trinh

Dr. Muoi A. Trinh is an Associate Professor in the Department of Anesthesiology and Perioperative Pain Medicine, as well as Cardiovascular Surgery at the Icahn School of Medicine at Mount Sinai. As Medical Director of Sustainability for the Mount Sinai Health System (MSHS), she leads the organization’s decarbonization and environmental stewardship efforts, integrating sustainability into clinical care and hospital operations.

Dr. Trinh directs system-wide initiatives to reduce greenhouse gas emissions across healthcare delivery, with a focus on high-impact areas including anesthetic gases, pharmaceuticals, supply chain, and energy use. She has led the development of Mount Sinai’s comprehensive decarbonization strategy and greenhouse gas inventory, enabling targeted, data-driven approaches to reduce environmental impact while maintaining high-quality patient care. Her work has resulted in meaningful reductions in waste, emissions, and costs through initiatives such as transitioning to reusable medical equipment, optimizing medication use, and advancing more sustainable perioperative practices. Beyond her institutional role, she is also involved in incorporating sustainability into the medical student curriculum at the Icahn School of Medicine, with the goal of preparing future physicians to address climate-related health considerations in clinical practice.

She serves on the MSHS Executive Committee on Sustainability, where she manages alignment with public commitments including the New York City Carbon Challenge and the New York State Insurance Fund Climate Action Pledge. In addition to her internal leadership, Dr. Trinh engages with the broader dialogue on planetary health, discussing the economic and health imperatives of climate action at forums such as the Clinical Climate Conference, Climate Week NYC, and in media podcasts focused on healthcare sustainability.

Hemali Sudhalkar

MD, MPH, SFHM

Hemali Sudhalkar, MD, MPH, SFHM, is an Internal Medicine hospitalist and palliative care physician at The Permanente Medical Group in San Jose, California. She serves as Regional Medical Director of Hospital Strategic Initiatives for Kaiser Permanente Northern California, supporting 21 medical centers. In this role, she leads systemwide programs including Advanced Care at Home and PACE programs and serves as National Medical Director of Strategy for Kaiser Permanente Care at Home. Dr. Sudhalkar completed her medical education in India and earned a Master of Public Health from Emory University. She is dedicated to ensuring every patient receives the highest-quality care in the right setting and at the right time, with a holistic focus on patients and families. A Six Sigma Black Belt, she applies lean methodologies to improve care delivery and operational performance. Her passion is fostering collaborative environments, strengthening culture, and creating exceptional experiences for patients, physicians, and care teams to achieve outstanding quality outcomes.

Scott LaRue

MBA, RD

For more than a decade, Scott LaRue has served as president and CEO of ArchCare, the non-profit healthcare system of the Archdiocese of New York. Under his leadership, the organization has evolved into one of the nation’s largest Catholic healthcare ministries, growing from a traditional nursing home provider into a dynamic continuum of care. Today, ArchCare’s 4,400 members serve over 10,000 people daily through skilled nursing, home care, hospice, and specialized programs for complex health needs.

LaRue has spearheaded over $200 million in capital improvements and successfully navigated the system through the COVID-19 pandemic with significant investments in infectious disease prevention. His tenure is marked by innovative expansions, including the opening of the Center for Advanced Memory Care and the growth of the Senior Life PACE program. As a leading advocate for the PACE model, which delivers nursing-home-level care to elders at home, LaRue now chairs the New York State PACE Alliance.

A Registered Dietitian with an MBA from Syracuse University, LaRue brought extensive leadership experience from Loretto in Upstate New York before joining ArchCare in 2007. Beyond his role as CEO, he is an active member of the Greater New York Hospital Association and serves on the New York State Public Health and Health Planning Council. His career remains dedicated to expanding access and improving the quality of care for New York’s most vulnerable populations.

Alexi Nazem

MD, MBA

Alexi Nazem, MD, MBA, is a General Partner leading the Healthcare team at AlleyCorp, where he oversees investments and incubations across healthcare technologies and services. Prior to AlleyCorp, Alexi co-founded Nomad Health, a digital marketplace for clinical talent, where he served as the company’s CEO for nine years.

Alexi is also a Clinical Assistant Professor of Medicine at Weill Cornell. Previously, he was a part of the leadership team of the 100,000 Lives Campaign at the Institute for Healthcare Improvement. Board-certified in Internal Medicine, Alexi previously practiced at New York Presbyterian Hospital and completed residency at Harvard’s Brigham and Women’s Hospital. He graduated from Yale University, earning an MD from the Yale School of Medicine and an MBA at Harvard Business School.

Namita Seth Mohta

Namita Seth Mohta is a physician executive with expertise in health care delivery transformation. As the Executive Editor for NEJM Catalyst Innovations in Care Delivery, an academic journal published by The New England Journal of Medicine, Dr Mohta is part of the founding leadership team and has responsibility for content strategy and quality. Dr Mohta also co-leads the Navigating Aging and Illness portfolio at Ariadne Labs, a health system innovation center at Brigham and Women’s Hospital and the Harvard T.H. Chan School of Public Health. She is the Principal Investigator for grant-funded projects focused on testing and scaling improvements in whole-person care, dementia, primary care, and chronic disease. Prior to this expanded portfolio, Dr Mohta served as the director of the Serious Illness Care Program (SICP) at Ariadne. The SICP is focused on the design, test, and spread of solutions to improve care for patients and caregivers experiencing serious illness. To date, SICP has trained over 300,000 clinicians and touched over 7 million patients worldwide with its Serious Illness Conversation Guide to ensure care is aligned with what matters most to patients.

Dr. Mohta has been part of the founding Population Health leadership teams as Medical Director, both at Mass General Brigham and Tufts Medical Center in Boston. Her responsibilities have included designing and implementing value-based care with a focus on scaling tailored clinical interventions, integrating analytics and measurement, and leading system-wide change management efforts for populations under risk contracts. Dr. Mohta has worked with multiple start-ups, including PatientPing (now Bamboo Health), a digital health company, as their physician lead, with a focus on building products that improve coordination of care. She often advises organizations to provide strategic and technical expertise and leadership, currently with Ianacare. Ianacare supports family caregivers with tech-enabled solutions to improve outcomes for patients with serious illness, including dementia. Prior to medical training, Dr Mohta worked as a management consultant with the Boston Consulting Group.

Dr. Mohta practices internal medicine as a hospitalist at Brigham and Women’s Hospital and is Assistant Professor in the Department of Medicine at Harvard Medical School and current Associate Faculty at Ariadne Labs. She completed her internal medicine and primary care residency training at Brigham and Women’s Hospital. Dr. Mohta is a graduate of Yale College and Yale School of Medicine.

Lady Angela Wahleithner

DNP, MSN, RN, NEA-BC, FABC

Lady Angela Wahleithner, DNP, MSN, RN, NEA-BC, FABC is a nationally recognized healthcare executive with more than 30 years of progressive leadership experience across acute, post-acute, and home-based care delivery models. She currently serves as Vice President, National Acute Care at Home for Kaiser Permanente, where she leads the national strategy, development, and implementation of the largest hospital-at-home program in the United States. Dr. Wahleithner is known for driving large-scale care delivery transformation, aligning enterprise strategy with regional execution, and leading complex, multidisciplinary organizations through change. Her expertise spans Medicare and complex populations, continuum optimization, hospital capacity strategy, and innovative models of care, with a leadership approach grounded in operational discipline, emotional intelligence, and measurable results. Dr. Wahleithner holds a Doctor of Nursing Practice in Executive Leadership and has completed executive education at Harvard and Cornell Universities.